September 30, 2021
Dermavant Showcases New Long-Term Data from Phase 3 PSOARING 3 Trial of Tapinarof in Patients with Plaque Psoriasis at the 30th EADV Virtual Congress
READ MORE
September 23, 2021
Dermavant to Present New Data on Phase 3 PSOARING Program at 30th EADV Virtual Congress
READ MORE
September 9, 2021
Dermavant Announces First Patient Dosed in ADORING, its Pivotal Phase 3 Clinical Program for Tapinarof for the Topical Treatment of Atopic Dermatitis
READ MORE
